( 01801.hk)
市盈率-62.56市净率5.13市销率10.36股息率0.00%上市时间2018-10-31股价43.45港币 (-1.14% , 2.82亿港币) 市值707.92亿港币总股本16.29亿上市至今年化投资收益率17.52%港股通持仓占H股比例20.47%累计做空占H股比例2.58%
所属三级行业药品 (恒生) 市盈率16.93市净率1.34市销率1.04股息率3.05%
所属指数指数纳入纳出
备注 (4): 双击编辑备注
发表讨论

信达生物(01801) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1ZIEZIULA GaryIndependent Non Executive Director2022-06-01--
2陳凱先Independent Non Executive Director2018-10-18--
3許懿尹Independent Non Executive Director - A/F2018-10-18--
4奚浩Executive Director2018-06-04--
5陳樹云Non Executive Director2018-01-312022-02-25
6COONEY Leland CharlesIndependent Non Executive Director2016-09-26--
7俞德超Executive DirectorChairman, CEO2011-04-28--